Study of Bortezomib and Revlimid™ for Patients Relapsing or Progressing on Total Therapy II

Clinical trial NCT00093028 · COMPLETED

Trial details

NCT number: NCT00093028
Sponsor: University of Arkansas
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2004-01-01
Primary completion: 2006-01-01
Enrollment: 315

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.